| Suzanne Lenhard, RN | |
|
34228 Sassafras Rd, Millsboro, DE 19966-6325 | |
| (302) 897-2471 | |
| Not Available |
| Full Name | Suzanne Lenhard |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 34228 Sassafras Rd, Millsboro, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043905235 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | L100934070 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Suzanne Lenhard, RN 34228 Sassafras Rd, Millsboro, DE 19966-6325 Ph: (302) 897-2471 | Suzanne Lenhard, RN 34228 Sassafras Rd, Millsboro, DE 19966-6325 Ph: (302) 897-2471 |
News Archive
When it comes to some of the health hazards of light at night, a new study suggests that the color of the light can make a big difference.
The Republic of Burundi will next week accelerate its fight against pneumonia, the world's biggest killer of children under five, when it becomes the tenth African country to introduce new pneumococcal vaccines.
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, and SpringWorks Therapeutics, a clinical-stage rare disease and oncology company focused on sourcing and developing innovative treatments for underserved patient populations, announced today that the companies have entered into a global clinical collaboration agreement to evaluate the safety, tolerability and preliminary efficacy of combining BeiGene's investigational RAF dimer inhibitor, lifirafenib and SpringWorks Therapeutics' investigational MEK inhibitor, PD-0325901, in patients with advanced solid tumors.
A recently published study in The Journal of Heart and Lung Transplantation shows that the patients who are most seriously ill before lung tranplantation have better one-year survival when Perfadex is used as the preservation solution for donor lungs compared with UW solution. Furthermore, the patients who received lungs preserved in Perfadex ran a significantly lower risk of being affected by rejection reactions requiring treatment.
› Verified 6 days ago
Kaylynn Renee White, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 35121 Lynch Rd, Millsboro, DE 19966 Phone: 302-296-7898 | |
Margaret Wright-stasi, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 213 E State St, Millsboro, DE 19966 Phone: 302-745-1509 | |
Kristina Santos, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 23581 Devonshire Rd, Millsboro, DE 19966 Phone: 302-258-7849 | |
Judy L Howett, FNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 230 Mitchell St, Millsboro, DE 19966 Phone: 302-648-2099 Fax: 302-648-2097 | |
Phyllis Ann Toomey, RN, BSN, CDE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 32060 Long Neck Rd, Millsboro, DE 19966 Phone: 302-947-2500 | |
Linda Butts, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 30029 Plantation Dr, Millsboro, DE 19966 Phone: 302-933-8512 |